Peringkat dalam Saham
#39749
Established in 2008 and based in York, United Kingdom, Abingdon Health Plc is a... Established in 2008 and based in York, United Kingdom, Abingdon Health Plc is a global entity dedicated to the creation, production, and worldwide distribution of diagnostic instruments. Their product line features the AbC-19 Rapid Test, a fast-acting diagnostic for COVID-19 IgG antibodies, alongside various nucleic acid lateral flow immunoassays. They also offer Seralite, a swift lateral flow test for accurately measuring kappa and lambda immunoglobulin free light chains in blood serum. Additionally, their AppDx technology converts any smartphone into an autonomous and adaptable lateral-flow reader. Beyond these offerings, the company provides expert services in lateral flow development and manufacturing, as well as advisory support to firms in the health tech industry. Abingdon Health Plc also engages in a collaborative and co-marketing partnership with Abcam plc.
Kapitalisasi Pasar
$378.31K
Perubahan (1 tahun)
77.02%
Perdagangan Abingdon Health Plc (ABDX)
Harga ABDX dengan kapitalisasi pasar B
Kapitalisasi pasar dari Abingdon Health Plc(ABDX)
Kapitalisasi Pasar: $378.31K
Per August 2026, Abingdon Health Plc memiliki kapitalisasi pasar sebesar $378.31K. Ini menjadikan Abingdon Health Plc sebagai perusahaan 39749th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Abingdon Health Plc dari 2020 hingga 2026
ABDX dibandingkan dengan 5 teratas stocks paling populer
| Harga ABDX |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.470T
|
+1,445,774,055.50%
|
|
|
|
|
$4.467T
|
+1,180,790,006.69%
|
|
|
|
|
$4.174T
|
+1,103,424,022.58%
|
|
|
|
|
$3.700T
|
+978,048,935.32%
|
|
|
|
|
$2.854T
|
+754,494,168.69%
|
